Funding Opportunity: RFA-AI-17-028 Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 – Clinical Trials Optional)

September 12, 2017

NIAD and NIMH will be accepting applications to support the development of new and innovative multipurpose prevention technologies (MPTs) with the dual purpose of contraception and HIV prevention. Letters of Intent due 19 February 2018.